Cargando…

Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study

BACKGROUND: Systemic inflammation and insulin resistance (IR) are often associated with poor prognosis in cancer. This study aimed to investigate the prognostic value of surrogate systemic inflammation and IR indices in patients with cancer. METHODS: This multicenter prospective study included 5,221...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Guo-Tian, Xie, Hai-Lun, Gong, Yi-Zhen, Ge, Yi-Zhong, Zhang, Qi, Wang, Zi-Wen, Zhang, Xi, Zhang, He-Yang, Tang, Meng, Song, Meng-Meng, Zhang, Xiao-Wei, Yang, Ming, Chen, Yong-Bing, Yu, Kai-Ying, Deng, Li, Wang, Kun-Hua, Cong, Ming-Hua, Shi, Han-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233357/
https://www.ncbi.nlm.nih.gov/pubmed/35752767
http://dx.doi.org/10.1186/s12885-022-09752-5
_version_ 1784735746022703104
author Ruan, Guo-Tian
Xie, Hai-Lun
Gong, Yi-Zhen
Ge, Yi-Zhong
Zhang, Qi
Wang, Zi-Wen
Zhang, Xi
Zhang, He-Yang
Tang, Meng
Song, Meng-Meng
Zhang, Xiao-Wei
Yang, Ming
Chen, Yong-Bing
Yu, Kai-Ying
Deng, Li
Wang, Kun-Hua
Cong, Ming-Hua
Shi, Han-Ping
author_facet Ruan, Guo-Tian
Xie, Hai-Lun
Gong, Yi-Zhen
Ge, Yi-Zhong
Zhang, Qi
Wang, Zi-Wen
Zhang, Xi
Zhang, He-Yang
Tang, Meng
Song, Meng-Meng
Zhang, Xiao-Wei
Yang, Ming
Chen, Yong-Bing
Yu, Kai-Ying
Deng, Li
Wang, Kun-Hua
Cong, Ming-Hua
Shi, Han-Ping
author_sort Ruan, Guo-Tian
collection PubMed
description BACKGROUND: Systemic inflammation and insulin resistance (IR) are often associated with poor prognosis in cancer. This study aimed to investigate the prognostic value of surrogate systemic inflammation and IR indices in patients with cancer. METHODS: This multicenter prospective study included 5,221 patients with cancer, with a mean age of 59.41±11.15 years, of whom 3,061 (58.6%) were male. The surrogate IR indices included low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LHR) ratio, total cholesterol to high-density lipoprotein cholesterol (TC/ HDL-c) ratio, triglyceride to high-density lipoprotein cholesterol (TG/HDL-c) ratio, and fasting triglyceride glucose (TyG). Prognostic receiver operator characteristic (ROC) curves and C-indices were used to select a better surrogate IR index in patients with cancer. The prognostic value of the indicators was evaluated using univariate and multivariate survival analyses. RESULTS: In this study, the median survival time of patients was 44.5 (40.5–51.4) months, and the overall mortality in the 12-month period was 1,115 (53.7%), with 196 mortality events per 1,000 patient-years of patients’ follow-up. The prognostic ROC curve and C-index suggested that the prognostic value of LHR was better than that of the other IR indices. The multivariate-adjusted hazard ratios (HRs) for overall survival (OS) were higher in patients with high C-reactive protein (CRP) (HR, 1.51; 95% confidence interval [CI]: 1.38–1.65) and high LHR (HR, 1.20; 95% CI: 1.06–1.37), respectively. The mortality rate of patients with both high CRP and LHR was 1.75-fold higher than that of patients with both low CRP and LHR. CONCLUSION: Both CRP and LHR showed good survival predictions in patients with cancer. CRP combined with LHR can improve the predictive power of patients with cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09752-5.
format Online
Article
Text
id pubmed-9233357
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92333572022-06-26 Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study Ruan, Guo-Tian Xie, Hai-Lun Gong, Yi-Zhen Ge, Yi-Zhong Zhang, Qi Wang, Zi-Wen Zhang, Xi Zhang, He-Yang Tang, Meng Song, Meng-Meng Zhang, Xiao-Wei Yang, Ming Chen, Yong-Bing Yu, Kai-Ying Deng, Li Wang, Kun-Hua Cong, Ming-Hua Shi, Han-Ping BMC Cancer Research BACKGROUND: Systemic inflammation and insulin resistance (IR) are often associated with poor prognosis in cancer. This study aimed to investigate the prognostic value of surrogate systemic inflammation and IR indices in patients with cancer. METHODS: This multicenter prospective study included 5,221 patients with cancer, with a mean age of 59.41±11.15 years, of whom 3,061 (58.6%) were male. The surrogate IR indices included low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LHR) ratio, total cholesterol to high-density lipoprotein cholesterol (TC/ HDL-c) ratio, triglyceride to high-density lipoprotein cholesterol (TG/HDL-c) ratio, and fasting triglyceride glucose (TyG). Prognostic receiver operator characteristic (ROC) curves and C-indices were used to select a better surrogate IR index in patients with cancer. The prognostic value of the indicators was evaluated using univariate and multivariate survival analyses. RESULTS: In this study, the median survival time of patients was 44.5 (40.5–51.4) months, and the overall mortality in the 12-month period was 1,115 (53.7%), with 196 mortality events per 1,000 patient-years of patients’ follow-up. The prognostic ROC curve and C-index suggested that the prognostic value of LHR was better than that of the other IR indices. The multivariate-adjusted hazard ratios (HRs) for overall survival (OS) were higher in patients with high C-reactive protein (CRP) (HR, 1.51; 95% confidence interval [CI]: 1.38–1.65) and high LHR (HR, 1.20; 95% CI: 1.06–1.37), respectively. The mortality rate of patients with both high CRP and LHR was 1.75-fold higher than that of patients with both low CRP and LHR. CONCLUSION: Both CRP and LHR showed good survival predictions in patients with cancer. CRP combined with LHR can improve the predictive power of patients with cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09752-5. BioMed Central 2022-06-25 /pmc/articles/PMC9233357/ /pubmed/35752767 http://dx.doi.org/10.1186/s12885-022-09752-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ruan, Guo-Tian
Xie, Hai-Lun
Gong, Yi-Zhen
Ge, Yi-Zhong
Zhang, Qi
Wang, Zi-Wen
Zhang, Xi
Zhang, He-Yang
Tang, Meng
Song, Meng-Meng
Zhang, Xiao-Wei
Yang, Ming
Chen, Yong-Bing
Yu, Kai-Ying
Deng, Li
Wang, Kun-Hua
Cong, Ming-Hua
Shi, Han-Ping
Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
title Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
title_full Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
title_fullStr Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
title_full_unstemmed Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
title_short Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
title_sort prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233357/
https://www.ncbi.nlm.nih.gov/pubmed/35752767
http://dx.doi.org/10.1186/s12885-022-09752-5
work_keys_str_mv AT ruanguotian prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT xiehailun prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT gongyizhen prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT geyizhong prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT zhangqi prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT wangziwen prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT zhangxi prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT zhangheyang prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT tangmeng prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT songmengmeng prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT zhangxiaowei prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT yangming prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT chenyongbing prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT yukaiying prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT dengli prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT wangkunhua prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT congminghua prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy
AT shihanping prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy